Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status

Background: Cough-variant asthma (CVA) and cough-predominant asthma (CPA) are the major causes of persistent cough in Japan. The utility of fractional exhaled nitric oxide (FeNO) measurement in the differential diagnosis of persistent cough has been reported, but the influence of atopic status, whic...

Full description

Bibliographic Details
Main Authors: Takamitsu Asano, Masaya Takemura, Kensuke Fukumitsu, Norihisa Takeda, Hiroya Ichikawa, Hisatoshi Hijikata, Yoshihiro Kanemitsu, Takehiro Uemura, Osamu Takakuwa, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Atsushi Nakamura, Akio Niimi
Format: Article
Language:English
Published: Elsevier 2017-04-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893016301344
id doaj-0ee56719a116439fa9733ddabc926fe8
record_format Article
spelling doaj-0ee56719a116439fa9733ddabc926fe82020-11-25T00:14:37ZengElsevierAllergology International1323-89302017-04-0166234435010.1016/j.alit.2016.08.015Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic statusTakamitsu AsanoMasaya TakemuraKensuke FukumitsuNorihisa TakedaHiroya IchikawaHisatoshi HijikataYoshihiro KanemitsuTakehiro UemuraOsamu TakakuwaHirotsugu OhkuboKen MaenoYutaka ItoTetsuya OguriAtsushi NakamuraAkio NiimiBackground: Cough-variant asthma (CVA) and cough-predominant asthma (CPA) are the major causes of persistent cough in Japan. The utility of fractional exhaled nitric oxide (FeNO) measurement in the differential diagnosis of persistent cough has been reported, but the influence of atopic status, which is associated with higher FeNO levels, on the diagnostic utility of FeNO has been unknown. Methods: We retrospectively analyzed 105 non-smoking patients with prolonged and chronic cough that were not treated with corticosteroids and anti-leukotrienes. Results: CPA was diagnosed in 37 patients, CVA in 40, and non-asthmatic cough (NAC) in 28. FeNO levels were significantly higher in the CPA [35.8 (7.0–317.9) ppb] and CVA [24.9 (3.1–156.0) ppb] groups than in the NAC group [18.2 (6.9–49.0) ppb] (p < 0.01 by Kruskal–Wallis test). The optimal cut-off for distinguishing asthmatic cough (AC; CPA and CVA) from NAC was 29.2 ppb [area under the curve (AUC) 0.74, p < 0.01]. Ninety-one percent of subjects with FeNO levels ≥29.2 ppb had AC. Meanwhile, 40% of AC patients had FeNO levels <29.2 ppb. Stratified cut-off levels were 31.1 ppb (AUC 0.83) in atopic subjects vs. 19.9 ppb (AUC 0.65) in non-atopic subjects (p = 0.03 for AUC). Conclusions: Although high FeNO levels suggested the existence of AC, lower FeNO levels had limited diagnostic significance. Atopic status affects the utility of FeNO levels in the differential diagnosis of prolonged and chronic cough.http://www.sciencedirect.com/science/article/pii/S1323893016301344AtopyChronic coughCough-predominant asthmaCough-variant asthmaFractional exhaled nitric oxide
collection DOAJ
language English
format Article
sources DOAJ
author Takamitsu Asano
Masaya Takemura
Kensuke Fukumitsu
Norihisa Takeda
Hiroya Ichikawa
Hisatoshi Hijikata
Yoshihiro Kanemitsu
Takehiro Uemura
Osamu Takakuwa
Hirotsugu Ohkubo
Ken Maeno
Yutaka Ito
Tetsuya Oguri
Atsushi Nakamura
Akio Niimi
spellingShingle Takamitsu Asano
Masaya Takemura
Kensuke Fukumitsu
Norihisa Takeda
Hiroya Ichikawa
Hisatoshi Hijikata
Yoshihiro Kanemitsu
Takehiro Uemura
Osamu Takakuwa
Hirotsugu Ohkubo
Ken Maeno
Yutaka Ito
Tetsuya Oguri
Atsushi Nakamura
Akio Niimi
Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status
Allergology International
Atopy
Chronic cough
Cough-predominant asthma
Cough-variant asthma
Fractional exhaled nitric oxide
author_facet Takamitsu Asano
Masaya Takemura
Kensuke Fukumitsu
Norihisa Takeda
Hiroya Ichikawa
Hisatoshi Hijikata
Yoshihiro Kanemitsu
Takehiro Uemura
Osamu Takakuwa
Hirotsugu Ohkubo
Ken Maeno
Yutaka Ito
Tetsuya Oguri
Atsushi Nakamura
Akio Niimi
author_sort Takamitsu Asano
title Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status
title_short Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status
title_full Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status
title_fullStr Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status
title_full_unstemmed Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status
title_sort diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status
publisher Elsevier
series Allergology International
issn 1323-8930
publishDate 2017-04-01
description Background: Cough-variant asthma (CVA) and cough-predominant asthma (CPA) are the major causes of persistent cough in Japan. The utility of fractional exhaled nitric oxide (FeNO) measurement in the differential diagnosis of persistent cough has been reported, but the influence of atopic status, which is associated with higher FeNO levels, on the diagnostic utility of FeNO has been unknown. Methods: We retrospectively analyzed 105 non-smoking patients with prolonged and chronic cough that were not treated with corticosteroids and anti-leukotrienes. Results: CPA was diagnosed in 37 patients, CVA in 40, and non-asthmatic cough (NAC) in 28. FeNO levels were significantly higher in the CPA [35.8 (7.0–317.9) ppb] and CVA [24.9 (3.1–156.0) ppb] groups than in the NAC group [18.2 (6.9–49.0) ppb] (p < 0.01 by Kruskal–Wallis test). The optimal cut-off for distinguishing asthmatic cough (AC; CPA and CVA) from NAC was 29.2 ppb [area under the curve (AUC) 0.74, p < 0.01]. Ninety-one percent of subjects with FeNO levels ≥29.2 ppb had AC. Meanwhile, 40% of AC patients had FeNO levels <29.2 ppb. Stratified cut-off levels were 31.1 ppb (AUC 0.83) in atopic subjects vs. 19.9 ppb (AUC 0.65) in non-atopic subjects (p = 0.03 for AUC). Conclusions: Although high FeNO levels suggested the existence of AC, lower FeNO levels had limited diagnostic significance. Atopic status affects the utility of FeNO levels in the differential diagnosis of prolonged and chronic cough.
topic Atopy
Chronic cough
Cough-predominant asthma
Cough-variant asthma
Fractional exhaled nitric oxide
url http://www.sciencedirect.com/science/article/pii/S1323893016301344
work_keys_str_mv AT takamitsuasano diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT masayatakemura diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT kensukefukumitsu diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT norihisatakeda diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT hiroyaichikawa diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT hisatoshihijikata diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT yoshihirokanemitsu diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT takehirouemura diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT osamutakakuwa diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT hirotsuguohkubo diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT kenmaeno diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT yutakaito diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT tetsuyaoguri diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT atsushinakamura diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
AT akioniimi diagnosticutilityoffractionalexhalednitricoxideinprolongedandchroniccoughaccordingtoatopicstatus
_version_ 1725389596932440064